Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP977855.RAV3ALvW9qlkzFYBvK-Je1NH3M43OLokSJs4-Cw34VDGQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP977855.RAV3ALvW9qlkzFYBvK-Je1NH3M43OLokSJs4-Cw34VDGQ130_assertion type Assertion NP977855.RAV3ALvW9qlkzFYBvK-Je1NH3M43OLokSJs4-Cw34VDGQ130_head.
- NP977855.RAV3ALvW9qlkzFYBvK-Je1NH3M43OLokSJs4-Cw34VDGQ130_assertion description "[In the CT26 mouse model of colon carcinoma, therapeutic vaccination with a lead PsifB::sseJ-coSVN construct (p8032) produced CXCR3-dependent infiltration of tumors by CD8 T cells, reversed the CD8:Treg ratio at the tumor site, and triggered potent antitumor activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977855.RAV3ALvW9qlkzFYBvK-Je1NH3M43OLokSJs4-Cw34VDGQ130_provenance.
- NP977855.RAV3ALvW9qlkzFYBvK-Je1NH3M43OLokSJs4-Cw34VDGQ130_assertion evidence source_evidence_literature NP977855.RAV3ALvW9qlkzFYBvK-Je1NH3M43OLokSJs4-Cw34VDGQ130_provenance.
- NP977855.RAV3ALvW9qlkzFYBvK-Je1NH3M43OLokSJs4-Cw34VDGQ130_assertion SIO_000772 25213323 NP977855.RAV3ALvW9qlkzFYBvK-Je1NH3M43OLokSJs4-Cw34VDGQ130_provenance.
- NP977855.RAV3ALvW9qlkzFYBvK-Je1NH3M43OLokSJs4-Cw34VDGQ130_assertion wasDerivedFrom befree-20150227 NP977855.RAV3ALvW9qlkzFYBvK-Je1NH3M43OLokSJs4-Cw34VDGQ130_provenance.
- NP977855.RAV3ALvW9qlkzFYBvK-Je1NH3M43OLokSJs4-Cw34VDGQ130_assertion wasGeneratedBy ECO_0000203 NP977855.RAV3ALvW9qlkzFYBvK-Je1NH3M43OLokSJs4-Cw34VDGQ130_provenance.